You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

ACOG MEMBER SUBSCRIPTION ACCESS

If you are an ACOG Fellow and have not logged in or registered to Obstetrics & Gynecology, please follow these step-by-step instructions to access journal content with your member subscription.

PostLoop Electrosurgical Excision Procedure Sepsis in a Human Immunodeficiency VirusInfected Woman

Szymanski, Linda M. MD, PhD1; Little, Richard MD2; Matthews, Douglas C. MS, CRNP2; Stratton, Pamela MD1

Obstetrics & Gynecology:
doi: 10.1097/01.AOG.0000171107.88468.29
Case Report
Abstract

BACKGROUND: Squamous intraepithelial lesions are more prevalent in women infected with the human immunodeficiency virus (HIV) compared with immunocompetent women. Loop electrosurgical excision procedure (LEEP) is commonly used to treat squamous intraepithelial lesions because it may be performed as an outpatient procedure with minimal blood loss and a low complication rate.

CASE: We report a major infectious post-LEEP complication in an HIV-infected female who had an uneventful LEEP in which a cellulose hemostatic agent was used. Despite the severity of the infection, she was successfully treated with a minor surgical procedure along with broad antibiotic coverage.

CONCLUSION: Although a cellulose hemostatic agent contaminated with perineal secretions may have served as a nidus for infection, use of perioperative antibiotics or cervical cleansing should be considered to prevent sepsis in immunocompromised hosts.

In Brief

Sepsis occurred in an HIV-infected woman after an uneventful loop electrosurgical excision procedure and was successfully treated with broad-spectrum antibiotics and minor surgery.

Author Information

From the 1Pediatric and Reproductive Endocrinology Branch, National Institutes of Child Health and Human Development, National Institutes of Health; and 2AIDS Malignancy Clinical Research Section, Medical Oncology Clinical Research Unit, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Corresponding author: Pamela Stratton, MD, Chief, Gynecology Consult Service, Pediatric and Reproductive Endocrinology Branch, National Institutes of Child Health and Human Development, National Institutes of Health, Bldg. 10, CRC, Room 1–3140, 10 Center Drive MSC 1109, Bethesda, MD 20892–1109; e-mail: strattop@cc1.nichd.nih.gov.

© 2006 The American College of Obstetricians and Gynecologists